Date Item Type Full Text Status

Article

Clinical and neurocognitive changes with modafinil in obsessive–compulsive disorder : a case report. (2010) W. Dittrich, T. Johansen, A. Padhi, I.E. Smith, S.R. Chamberlain and Naomi Fineberg

Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder : remediating effects of dopaminergic D2/3 receptor agents. (2019) Jonathan W Kanen, Karen D Ersche, Naomi Fineberg, Trevor W Robbins and Rudolf N Cardinal

The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls. (2020) Christine Lochner, Samuel R. Chamberlain, Martin Kidd, Naomi Fineberg, Trevor W. Robbins and D.J. Stein

Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder. (2019) Graham Murray, Franziska Knolle, Karen D Ersche, Kevin J Craig, Sanja Abbott, Shaila S Shabbir, Naomi Fineberg, John Suckling, Barbara J. Sahakian, Edward T. Bullmore and Trevor W. Robbins

An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans. (2024) Elisabeth Prevete, Eef L. Theunissen, Kim P. C. Kuypers, Riccardo Paci, Johannes T. Reckweg, Mauro Cavarra, Stefan W. Toennes, Sabrina Ritscher, Giuseppe Bersani, Ornella Corazza, Massimo Pasquini and Johannes G. Ramaekers

Mephedrone (4-methylmethcathinone; 'meow meow') : chemical, pharmacological and clinical issues. (2011) Fabrizio Schifano, Antonio Albanese, Suzanne Fergus, Jacqueline Stair, Paolo Deluca, Ornella Corazza, Zoe Davey, John Corkery, Holger Siemann, Norbert Scherbaum, Magi' Farre', Marta Torrens, Zsolt Demetrovics and A. Hamid Ghodse